Erratum: Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients (Journal of Clinical Endocrinology and Metabolism (2012) 97 (E129-E135) DOI: 10.1210/jc.2011-1796);Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages 1294-

  Kang, Eun Seok ^a,c   Magkos, Faidon ^e   Kim, Beom Seok ^a,c   Zhai, Rihong ^b   Su, Li ^b   Kim, Yu Seun ^a,d   Christiani, David C ^b   Lee, Hyun Chul ^c   Mantzoros, Christos S ^a,b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e HAROKOPIO UNIVERSITY   (Greece)

^f Division of SCI Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ANTIDIABETIC AGENT; CYCLOSPORIN; DEFLAZACORT; GLUCOCORTICOID; GLUCOSE; PREDNISOLONE; TACROLIMUS;

ADIPOQ GENE; ADIPOR1 GENE; ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG POTENCY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT REJECTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRON; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; POSTTRANSPLANTATION DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

EID: 84862968289     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1320     Document Type: Erratum

References (32)

1. Bonato V, Cataldo D, Dotta F, Carmellini M 2009 Diagnosis and approach to posttransplant diabetes. Curr Diab Rep 9:317-323
2. Young JB, Neumayer HH, Gordon RD 2010 Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk. Kidney Int 78(Suppl 118):S1-S7
3. Gomes MB, Cobas RA 2009 Post-transplant diabetes mellitus. Diabetol Metab Syndr 1:14
4. Kang ES, Kim MS, Kim YS, Hur KY, Han SJ, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC 2008 A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care 31:63-68
5. Kang ES, Kim MS, Kim CH, Nam CM, Han SJ, Hur KY, Ahn CW, Cha BS, Kim SI, Lee HC, Kim YS 2009 Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea. Transplantation 88:693-698
6. Kang ES, Kim MS, Kim YS, Kim CH, Han SJ, Chun SW, Hur KY, NamCM, Ahn CW, Cha BS, Kim SI, Lee HC 2008 Apolymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes 57:1043-1047
7. Menzaghi C, Trischitta V, Doria A 2007 Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56:1198-1209
8. Siitonen N, Pulkkinen L, Mager U, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M 2006 Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 49:1795-1805
9. Damcott CM, Ott SH, Pollin TI, Reinhart LJ, Wang J, O'connell JR, Mitchell BD, Shuldiner AR 2005 Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54:2245-2250
10. Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, Boirie Y, Vidal H 2004 Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 47:917-925
11. Davidson JA, Wilkinson A 2004 New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 27:805-812
12. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB 2005 New-onset diabetes after kidney transplantation: an application of 2003 international guidelines. Transplantation 80:945-952
13. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH 2007 New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 36:873-890; vii
14. Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC 2007 Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 30:609-615
15. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T 2002 Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540
16. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Leprêtre F, Dupont S, Hara K, Clément K, Bihain B, Kadowaki T, Froguel P 2002 Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614
17. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B 2008 Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 300:1523-1531
18. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A 2002 Ahaplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306-2312
19. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M,Fallarino M, Sorropago G, Baroni MG 2005 The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
20. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B 2006 Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55:375-384
21. Soccio T, Zhang YY, Bacci S, Mlynarski W, Placha G, Raggio G, Di Paola R, Marucci A, Johnstone MT, Gervino EV, Abumrad NA, Klein S, Trischitta V, Doria A 2006 Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes. Diabetes 55:2763-2770
22. Yamaguchi S, Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K, Nozawa Y 2007 Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus. Int J Mol Med 19:631-637
23. Sun L, Yang Z, Jin F, Zhu XQ, Qu YC, Shi XH, Wang L 2006 The Gly482Ser variant of the PPARGC1 gene is associated with type 2 diabetes mellitus in northern Chinese, especially men. Diabet Med 23:1085-1092
24. Chalvatzas N, Dafopoulos K, Kosmas G, Kallitsaris A, Pournaras S, Messinis IE 2009 Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil Steril 91:1189-1194
25. Høst C, Bojesen A, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH 2010 Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome. Eur J Clin Invest 40:211-219
26. Kunnari A, Santaniemi M, Jokela M, Karjalainen AH, Heikkinen J, Ukkola O, Kesäniemi YA 2008 Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. Metabolism 57:1509-1515
27. Louet JF, LeMay C, Mauvais-Jarvis F 2004 Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6:180-185
28. Yoshihara R, Utsunomiya K, Gojo A, Ishizawa S, Kanazawa Y, Matoba K, Taniguchi K, Yokota T, Kurata H, Yokoyama J, Urashima M, Tajima N 2009 Association of polymorphism of estrogen receptor-α gene with circulating levels of adiponectin in postmenopausal women with type 2 diabetes. J Atheroscler Thromb 16:250-255
29. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, Park HJ, Youn BS, Lee HK, Park KS, Shin HD 2005 Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet Med 22:569-575
30. WooJG, Dolan LM, Deka R, Kaushal RD,Shen Y, Pal P, Daniels SR, Martin LJ 2006 Interactions between noncontiguous haplotypes in the adiponectin geneACDCare associated with plasma adiponectin. Diabetes 55:523-529
31. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ 2006 Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17:2599-2606
32. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P 2005 Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112:1756-1762